BioSpace News Archive

Press Releases

IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases

January 22, 2025
·
5 min read
Press Releases

Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer

January 22, 2025
·
6 min read
Press Releases

Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication

January 22, 2025
·
6 min read
Press Releases

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

January 22, 2025
·
2 min read
Press Releases

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Registration Link for Presentation and live Q&A to take place, Wednesday January 29, 2025 at 2:00 pm EST

January 22, 2025
·
4 min read
Press Releases

MEDITECH Shares Strategies for Interconnected Care and Meaningful Data Exchange at ViVE 2025

January 22, 2025
·
4 min read
Press Releases

Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain

January 22, 2025
·
5 min read
Press Releases

Hemostemix Announces Grant of Stock Options

January 22, 2025
·
6 min read
Press Releases

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

January 22, 2025
·
2 min read
Press Releases

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

January 22, 2025
·
7 min read